Dev

A scientific team led by the Gladstone Institutes and UC San Francisco has discovered that a common form of a gene already associated with long life also improves learning and memory, a finding that could have implications for treating age-related…

Conditions which may accelerate the spread of Parkinson’s disease, and a potential means of enhancing naturally-occurring defences against neurodegenerative disorders, have been identified in two new studies. Both sets of results have emerged from collaborations between the research groups led…

The three Dementia Challenge Champion Groups have written brief reports detailing their progress during the past year. These reports feature in a letter to the UK Prime Minister which also reiterates achievements since the Prime Minister’s Dementia Challenge was launched…

French research into the impact of a premature menopause (less than 40 years old) on cognitive function in later life indicates that premature surgical menopause and premature ovarian failure are associated with long-term negative effects on cognitive function. These effects…

A glucagon-like peptide-1 agonist (GLP-1 agonist) medication, Exenatide, marketed as Byetta® and Bydureon® is used in the treatment of insulin resistance in patients with Type 2 diabetes. Several recent discoveries have highlighted common cellular pathways that potentially relate neurodegenerative processes…

Are patients with Parkinson’s disease “blind to blindsight?” That’s not a trick question, but the focus of an inquiry by neuroscientists from Rush University Medical Center as well as the Centre Hospitalier and University of Luxembourg. Scientists have developed the…

A recent study conducted by researchers from the Mayo Clinic in Florida examines the discovery of an atypical type of Alzhiemer’s–one that neuroscientists claim is not well recognized nor appropriately treated. The variant, called hippocampal sparing AD, made up 11…

According to the results of the EU FP7-funded REPLACES project (completed 2013), the pattern of brain alterations may be similar in several different neurodegenerative diseases, which may lead to alternative therapeutic strategies to treat these diseases. The project sheds light…